Elías, E. E., Almejún, M. B., Colado, A., Cordini, G., Vergara Rubio, M., Podaza, E. A., . . . Gamberale, R. (2018). Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies. Web
Citación estilo ChicagoElías, Esteban Enrique, et al. Autologous T-cell Activation Fosters ABT-199 Resistance in Chronic Lymphocytic Leukemia: Rationale for a Combined Therapy With SYK Inhibitors and Anti-CD20 Monoclonal Antibodies. 2018.
Cita MLAElías, Esteban Enrique, et al. Autologous T-cell Activation Fosters ABT-199 Resistance in Chronic Lymphocytic Leukemia: Rationale for a Combined Therapy With SYK Inhibitors and Anti-CD20 Monoclonal Antibodies. 2018.